Survival Advantage With Decitabine Versus Intensive Chemotherapy in Patients With Higher Risk Myelodysplastic Syndrome

Cancer - United States
doi 10.1002/cncr.22508
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Assessment of ATRX Expression in Patients With Myelodysplastic Syndromes Treated With Decitabine

Leukemia Research
Cancer ResearchOncologyHematology
2009English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

Comparison of Risk Stratification Tools in Predicting Outcomes of Patients With Higher-Risk Myelodysplastic Syndromes Treated With Azanucleosides

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Elderly Gastric Cancer Patients With Myelodysplastic Syndrome

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2018English

Effective Treatment of Low-Dose Decitabine in Myelodysplastic Syndrome/Myeloproliferative Neoplasms

OncoTargets and Therapy
OncologyPharmacology
2017English

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Intermediate- And High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Hypomethylation of MIR‐378 5’‐flanking Region Predicts Poor Survival in Young Patients With Myelodysplastic Syndrome

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

A Retrospective Evaluation of Patients With Myelodysplastic Syndrome

Experimental Biomedical Research
2019English

Androgen Therapy for Patients With Lower-Risk Myelodysplastic Syndrome and Significant Cytopenia: A Retrospective Study

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy